BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16159780)

  • 21. Interaction between components of the type III secretion system of Chlamydiaceae.
    Slepenkin A; de la Maza LM; Peterson EM
    J Bacteriol; 2005 Jan; 187(2):473-9. PubMed ID: 15629918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.
    Hower S; Wolf K; Fields KA
    Mol Microbiol; 2009 Jun; 72(6):1423-37. PubMed ID: 19460098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multipart Chaperone-Effector Recognition in the Type III Secretion System of Chlamydia trachomatis.
    Shen L; Macnaughtan MA; Frohlich KM; Cong Y; Goodwin OY; Chou CW; LeCour L; Krup K; Luo M; Worthylake DK
    J Biol Chem; 2015 Nov; 290(47):28141-28155. PubMed ID: 26438824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model.
    Chellas-Géry B; Linton CN; Fields KA
    Cell Microbiol; 2007 Oct; 9(10):2417-30. PubMed ID: 17532760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.
    Slepenkin A; Enquist PA; Hägglund U; de la Maza LM; Elofsson M; Peterson EM
    Infect Immun; 2007 Jul; 75(7):3478-89. PubMed ID: 17470544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterologous Complementation Studies With the YscX and YscY Protein Families Reveals a Specificity for
    Gurung JM; Amer AAA; Francis MK; Costa TRD; Chen S; Zavialov AV; Francis MS
    Front Cell Infect Microbiol; 2018; 8():80. PubMed ID: 29616194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Scc1 (CP0432) and Scc4 (CP0033) function as a type III secretion chaperone for CopN of Chlamydia pneumoniae.
    Silva-Herzog E; Joseph SS; Avery AK; Coba JA; Wolf K; Fields KA; Plano GV
    J Bacteriol; 2011 Jul; 193(14):3490-6. PubMed ID: 21571996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and localization of predicted inclusion membrane proteins in Chlamydia trachomatis.
    Weber MM; Bauler LD; Lam J; Hackstadt T
    Infect Immun; 2015 Dec; 83(12):4710-8. PubMed ID: 26416906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Chlamydia trachomatis type III secretion substrates CT142, CT143, and CT144 are secreted into the lumen of the inclusion.
    da Cunha M; Pais SV; Bugalhão JN; Mota LJ
    PLoS One; 2017; 12(6):e0178856. PubMed ID: 28622339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative genomes of Chlamydia pneumoniae and C. trachomatis.
    Kalman S; Mitchell W; Marathe R; Lammel C; Fan J; Hyman RW; Olinger L; Grimwood J; Davis RW; Stephens RS
    Nat Genet; 1999 Apr; 21(4):385-9. PubMed ID: 10192388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type III Secretion in
    Rucks EA
    Microbiol Mol Biol Rev; 2023 Sep; 87(3):e0003423. PubMed ID: 37358451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Preliminary Characterization of Novel Type III Secreted Effector Proteins in Chlamydia trachomatis.
    McCaslin PN; Andersen SE; Icardi CM; Faris R; Steiert B; Smith P; Haider J; Weber MM
    Infect Immun; 2023 Jul; 91(7):e0049122. PubMed ID: 37347192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioinformatic and biochemical evidence for the identification of the type III secretion system needle protein of Chlamydia trachomatis.
    Betts HJ; Twiggs LE; Sal MS; Wyrick PB; Fields KA
    J Bacteriol; 2008 Mar; 190(5):1680-90. PubMed ID: 18165300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex.
    Spaeth KE; Chen YS; Valdivia RH
    PLoS Pathog; 2009 Sep; 5(9):e1000579. PubMed ID: 19750218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis.
    Mueller KE; Fields KA
    PLoS One; 2015; 10(8):e0135295. PubMed ID: 26258949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development.
    Fields KA; Mead DJ; Dooley CA; Hackstadt T
    Mol Microbiol; 2003 May; 48(3):671-83. PubMed ID: 12694613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infection.
    Bulir DC; Waltho DA; Stone CB; Mwawasi KA; Nelson JC; Mahony JB
    PLoS One; 2014; 9(6):e99315. PubMed ID: 24959658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetratricopeptide repeats in the type III secretion chaperone, LcrH: their role in substrate binding and secretion.
    Edqvist PJ; Bröms JE; Betts HJ; Forsberg A; Pallen MJ; Francis MS
    Mol Microbiol; 2006 Jan; 59(1):31-44. PubMed ID: 16359316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and targeting of secreted proteins from Chlamydia trachomatis.
    Bauler LD; Hackstadt T
    J Bacteriol; 2014 Apr; 196(7):1325-34. PubMed ID: 24443531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle.
    Bailey L; Gylfe A; Sundin C; Muschiol S; Elofsson M; Nordström P; Henriques-Normark B; Lugert R; Waldenström A; Wolf-Watz H; Bergström S
    FEBS Lett; 2007 Feb; 581(4):587-95. PubMed ID: 17257594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.